Chromatin state dynamics during blood formation

Science

Volumn 345, Issue 6199, 2014, Pages 943-949

  Lara Astiaso, David ^a   Weiner, Assaf ^b   Lorenzo Vivas, Erika ^a   Zaretsky, Irina ^a   Jaitin, Diego Adhemar ^a   David, Eyal ^a   Keren Shaul, Hadas ^a   Mildner, Alexander ^a   Winter, Deborah ^a   Jung, Steffen ^a   Friedman, Nir ^b   Amit, Ido ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; HISTONE;

BLOOD; CHROMATE; GENE; HEMATOLOGY; NUMERICAL MODEL;

ARTICLE; BLOOD; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING MOTIF; ENHANCER REGION; GENE EXPRESSION; HEMATOPOIESIS; HISTONE MODIFICATION; PRIORITY JOURNAL; ANIMAL; CELL LINEAGE; CHEMISTRY; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; CELL LINEAGE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HISTONES; MICE; TRANSCRIPTION FACTORS;

EID: 84907419194     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1256271     Document Type: Article

References (28)

1. L. Ho, G. R. Crabtree, Nature 463, 474-484 (2010).
2. V. W. Zhou, A. Goren, B. E. Bernstein, Nat. Rev. Genet. 12, 7-18 (2011).
3. S. Ghisletti et al., Immunity 32, 317-328 (2010).
4. E. M. Mercer et al., Immunity 35, 413-425 (2011).
5. G. Wei et al., Immunity 30, 155-167 (2009).
6. R. Revilla-i-Domingo et al., EMBO J. 31, 3130-3146 (2012).
7. T. S. Mikkelsen et al., Nature 448, 553-560 (2007).
8. J. Seita, I. L. Weissman, Wiley Interdiscip. Rev. Syst. Biol. Med. 2, 640-653 (2010).
9. S. Doulatov, F. Notta, E. Laurenti, J. E. Dick, Cell Stem Cell 10, 120-136 (2012).
10. A. H. Shih, O. Abdel-Wahab, J. P. Patel, R. L. Levine, Nat. Rev. Cancer 12, 599-612 (2012).
11. S. Heinz et al ., Mol. Cell 38, 576-589 (2010).
12. H. Ji et al., Nature 467, 338-342 (2010).
13. T. S. Furey, Nat. Rev. Genet. 13, 840-852 (2012).
14. P. Shankaranarayanan et al., Nat. Methods 8, 565-567 (2011).
15. M. Garber et al., Mol. Cell 47, 810-822 (2012).
16. Materials and methods are available as supplementary materials on Science Online.
17. C. M. Rivera, B. Ren, Cell 155, 39-55 (2013).
18. M. U. Kaikkonen et al., Mol. Cell 51, 310-325 (2013).
19. A. Rada-Iglesias et al., Nature 470, 279-283 (2011).
20. M. P. Creyghton et al., Proc. Natl. Acad. Sci. U.S.A. 107, 21931-21936 (2010).
21. T. A. Wynn, A. Chawla, J. W. Pollard, Nature 496, 445-455 (2013).
22. R. E. Thurman et al., Nature 489, 75-82 (2012).
23. J. D. Buenrostro, P. G. Giresi, L. C. Zaba, H. Y. Chang, W. J. Greenleaf, Nat. Methods 10, 1213- 1218 (2013).
24. L. A. Cirillo et al., Mol. Cell 9, 279-289 (2002).
25. A. B. Cantor, S. H. Orkin, Oncogene 21, 3368-3376 (2002).
26. W. Ouyang, M. O. Li, Trends Immunol. 32, 26-33 (2011).
27. T. Matsuyama et al., Cell 75, 83-97 (1993).
28. R. Yamanaka et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13187-13192 (1997).